Perritt Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Perritt Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-426,370	Closed	-$4.5M	–	240
2017 Q1	$4.5M	Buy	426,370 +1,200	+0.3%	+$11.6K	1.14%	23
2016 Q4	$3.57M	Buy	425,170 +600	+0.1%	+$4.7K	0.87%	39
2016 Q3	$3.04M	Buy	424,570 +6,200	+1%	+$43.1K	0.76%	46
2016 Q2	$3.22M	Buy	418,370 +41,870	+11%	+$298K	0.85%	43
2016 Q1	$2.75M	Sell	376,500 -23,500	-6%	-$168K	0.68%	69
2015 Q4	$3.08M	Hold	400,000	–	–	0.67%	65
2015 Q3	$2.86M	Hold	400,000	–	–	0.6%	73
2015 Q2	$4.25M	Hold	400,000	–	–	0.76%	50
2015 Q1	$4.95M	Hold	400,000	–	–	0.87%	30
2014 Q4	$3.73M	Hold	400,000	–	–	0.68%	63
2014 Q3	$4.01M	Hold	400,000	–	–	0.75%	52
2014 Q2	$4.13M	Hold	400,000	–	–	0.7%	61
2014 Q1	$4.98M	Hold	400,000	–	–	0.8%	34
2013 Q4	$4.92M	Buy	400,000 +20,000	+5%	+$208K	0.81%	43
2013 Q3	$3.28M	Buy	380,000 +48,000	+14%	+$414K	0.64%	75
2013 Q2	$2.89M	Buy	+332,000	New	+$2.97M	0.65%	72

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.58% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Perritt Capital Management's ELOS Position: Q2 2017 in Review

Perritt Capital Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 426,370 shares — an estimated $4.5M sold.

Perritt Capital Management first reported a position in ELOS in Q2 2013 and held it in 16 quarters. The position peaked at $4.98M in Q1 2014. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

Perritt Capital Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
Perritt Capital Management sold 426,370 Syneron Medical Ltd shares in Q2 2017, an estimated $4.5M.
Perritt Capital Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 16 quarters.
Perritt Capital Management's Syneron Medical Ltd position peaked at $4.98M in Q1 2014.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Perritt Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.